Meyer Larissa, Pothuri Bhavana
Columbia University, College of Physicians and Surgeons, 161 Fort Washington Avenue, Herbert Irving Pavilion, 8-837, New York, NY 10032, USA.
Curr Treat Options Oncol. 2006 Mar;7(2):111-20. doi: 10.1007/s11864-006-0046-1.
Percutaneous gastrostomy tube placement is a technically feasible and safe procedure for palliation in patients with small bowel obstruction (SBO) caused by advanced gynecologic malignancies. It is used commonly in patients who are poor surgical candidates, those who elect to not undergo surgery, and in patients with a limited lifespan because of end-stage cancer. Percutaneous gastrostomy tube placement is even technically possible in patients with tumor encasing the stomach, diffuse carcinomatosis, and ascites. Percutaneous endoscopic gastrostomy (PEG) tubes provide symptomatic relief of nausea and vomiting in most patients with advanced gynecologic cancer and SBO. PEG tube placement allows most patients to have end- of-life care at home or in an inpatient hospice. It is a cost effective procedure and is associated with low morbidity and mortality. Placement of PEG tubes should be highly considered in patients who present with recurrent bowel obstruction and who have undergone a prior operation for SBO in the setting of advanced gynecologic malignancy.
经皮胃造瘘管置入术对于由晚期妇科恶性肿瘤引起的小肠梗阻(SBO)患者的姑息治疗而言,是一项技术上可行且安全的操作。它常用于手术条件较差的患者、选择不接受手术的患者以及因终末期癌症而预期寿命有限的患者。即使在肿瘤包绕胃部、弥漫性癌转移和腹水的患者中,经皮胃造瘘管置入术在技术上也是可行的。经皮内镜下胃造瘘(PEG)管能使大多数晚期妇科癌症合并SBO的患者的恶心和呕吐症状得到缓解。PEG管置入术能让大多数患者在家中或住院临终关怀机构接受临终护理。这是一种具有成本效益的操作,且发病率和死亡率较低。对于晚期妇科恶性肿瘤患者中出现复发性肠梗阻且之前因SBO接受过手术的患者,应高度考虑置入PEG管。